Analysis of biomarkers within the initial 2 years posttransplant and 5-year kidney transplant outcomes: results from Clinical Trials in Organ Transplantation-17

BACKGROUND: An early posttransplant biomarker/surrogate marker for kidney allograft loss has the potential to guide targeted interventions. Previously published findings, including results from the Clinical Trials in Organ Transplantation (CTOT)-01 study, showed that elevated urinary chemokine CXCL9...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transplantation
Main Authors: Faddoul, Geovani, Nadkarni, Girish N, Bridges, Nancy D., Goebel, Jens, Hricik, Donald E., Formica, Richard, Menon, Madhav C, Morrison, Yvonne, Murphy, Barbara, Newell, Kenneth, Nickerson, Peter, Poggio, Emilio D., Rush, David, Heeger, Peter S.
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018026/
https://ncbi.nlm.nih.gov/pubmed/29189482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000002026
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares